{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:19:19Z","timestamp":1793031559246,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/01523-3"],"award-info":[{"award-number":["2019\/01523-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI07647"],"award-info":[{"award-number":["AI07647"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI097092-07"],"award-info":[{"award-number":["5P01AI097092-07"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI146101-01"],"award-info":[{"award-number":["R01-AI146101-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["AI07647"],"award-info":[{"award-number":["AI07647"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["5P01AI097092-07"],"award-info":[{"award-number":["5P01AI097092-07"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ymthe.2020.04.018","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T18:31:13Z","timestamp":1587321073000},"page":"1569-1584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":310,"title":["A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice"],"prefix":"10.1016","volume":"28","author":[{"given":"Alec W.","family":"Freyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamile","family":"Ramos da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria C.","family":"Rosado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly M.","family":"Bliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Pine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L.","family":"Mui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Carlos","family":"de Souza Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffael","family":"Nachbagauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.04.018_bib1","series-title":"Influenza (seasonal) fact sheet","year":"2020"},{"key":"10.1016\/j.ymthe.2020.04.018_bib2","series-title":"Seasonal influenza vaccine effectiveness, 2004\u20132019","year":"2019"},{"key":"10.1016\/j.ymthe.2020.04.018_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2020.04.018_bib4","first-page":"291","article-title":"Pandemic influenza vaccines","volume":"333","author":"DiMenna","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib5","doi-asserted-by":"crossref","first-page":"e00018-10","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.ymthe.2020.04.018_bib6","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1473-3099(19)30393-7","article-title":"Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial","volume":"20","author":"Bernstein","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2020.04.018_bib8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.04.018_bib9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.04.018_bib10","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J.\u00a0Hyg. (Lond.)"},{"key":"10.1016\/j.ymthe.2020.04.018_bib11","doi-asserted-by":"crossref","first-page":"e01463-17","DOI":"10.1128\/mBio.01463-17","article-title":"Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in\u00a0vivo protection in a serum transfer mouse challenge model","volume":"8","author":"Jacobsen","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.ymthe.2020.04.018_bib12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41591-019-0463-x","article-title":"Novel correlates of protection against pandemic H1N1 influenza A virus infection","volume":"25","author":"Ng","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.04.018_bib13","first-page":"ciz927","article-title":"Hemagglutinin-stalk antibody responses following trivalent inactivated influenza vaccine immunization of pregnant women and association with protection from influenza virus illness","author":"Dhar","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2020.04.018_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cell.2018.03.030","article-title":"Influenza infection in humans induces broadly cross-reactive and protective neuraminidase-reactive antibodies","volume":"173","author":"Chen","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.04.018_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1126\/science.aay0678","article-title":"Broadly protective human antibodies that target the active site of influenza virus neuraminidase","volume":"366","author":"Stadlbauer","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2020.04.018_bib16","doi-asserted-by":"crossref","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.ymthe.2020.04.018_bib17","first-page":"275","article-title":"Influenza neuraminidase as a vaccine antigen","volume":"386","author":"Eichelberger","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coi.2018.03.025","article-title":"Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness","volume":"53","author":"Eichelberger","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/vaccines3010105","article-title":"M2e-based universal influenza a vaccines","volume":"3","author":"Deng","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2020.04.018_bib20","doi-asserted-by":"crossref","first-page":"24402","DOI":"10.1038\/srep24402","article-title":"Long-lasting cross-protection against influenza a by neuraminidase and M2e-based immunization strategies","volume":"6","author":"Schotsaert","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2020.04.018_bib21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/srep01443","article-title":"Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1","volume":"3","author":"Lambe","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2020.04.018_bib22","doi-asserted-by":"crossref","first-page":"9359276","DOI":"10.1155\/2017\/9359276","article-title":"Immunogenicity and cross protection in mice afforded by pandemic H1N1 live attenuated influenza vaccine containing wild-type nucleoprotein","volume":"2017","author":"Rekstin","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ymthe.2020.04.018_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/vaccines6020020","article-title":"New kids on the block: RNA-based influenza virus vaccines","volume":"6","author":"Scorza","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2020.04.018_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2020.04.018_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2020.04.018_bib26","doi-asserted-by":"crossref","first-page":"e00833-16","DOI":"10.1128\/mBio.00833-16","article-title":"RNAs containing modified nucleotides fail to trigger RIG-I conformational changes for innate immune signaling","volume":"7","author":"Durbin","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.ymthe.2020.04.018_bib27","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2020.04.018_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","article-title":"PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake","volume":"291","author":"Parhiz","year":"2018","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2020.04.018_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fmicb.2011.00269","article-title":"Native morphology of influenza virions","volume":"2","author":"Noda","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib30","doi-asserted-by":"crossref","first-page":"e03300","DOI":"10.7554\/eLife.03300","article-title":"The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin","volume":"3","author":"Thyagarajan","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2020.04.018_bib31","doi-asserted-by":"crossref","first-page":"e00754-18","DOI":"10.1128\/JVI.00754-18","article-title":"The influenza B virus hemagglutinin head domain is less tolerant to transposon mutagenesis than that of the influenza A virus","volume":"92","author":"Fulton","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ni.3684","article-title":"Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins","volume":"18","author":"Nachbagauer","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib33","doi-asserted-by":"crossref","first-page":"e02332-17","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines?","volume":"9","author":"Krammer","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.ymthe.2020.04.018_bib34","first-page":"323","article-title":"Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies","volume":"386","author":"Lee","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12985-019-1188-7","article-title":"Diversity and distribution of type A influenza viruses: an updated panorama analysis based on protein sequences","volume":"16","author":"Zhuang","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.ymthe.2020.04.018_bib36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.04.018_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ebiom.2018.02.011","article-title":"Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults","volume":"29","author":"Coughlan","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2020.04.018_bib38","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1128\/JVI.75.12.5656-5662.2001","article-title":"Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity","volume":"75","author":"Watanabe","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib39","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.1128\/JVI.00969-13","article-title":"In\u00a0vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies","volume":"87","author":"Heaton","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib40","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jim.2014.07.010","article-title":"Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies","volume":"414","author":"Cheng","year":"2014","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ymthe.2020.04.018_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4049\/immunohorizons.1900022","article-title":"Chimeric hemagglutinin-based influenza virus vaccines induce protective stalk-specific humoral immunity and cellular responses in mice","volume":"3","author":"Choi","year":"2019","journal-title":"Immunohorizons"},{"key":"10.1016\/j.ymthe.2020.04.018_bib43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","article-title":"Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface","volume":"40","author":"Lamb","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.04.018_bib44","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2020.04.018_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-1702(01)00264-7","article-title":"Extracellular truncated influenza virus nucleoprotein","volume":"77","author":"Prokudina","year":"2001","journal-title":"Virus Res."},{"issue":"4","key":"10.1016\/j.ymthe.2020.04.018_bib46","first-page":"18","article-title":"[Detection of influenza virus nucleoprotein on the surface of infected cells and in free nonvirion form]","author":"Semenova","year":"1991","journal-title":"Mol. Gen. Mikrobiol. Virusol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib47","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2020.04.018_bib48","doi-asserted-by":"crossref","first-page":"eaaw7083","DOI":"10.1126\/sciimmunol.aaw7083","article-title":"Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes","volume":"4","author":"Awasthi","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib49","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","article-title":"Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses","volume":"25","author":"Bahl","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.04.018_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.04.018_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.03.016","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"169","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.04.018_bib52","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.vaccine.2018.01.029","article-title":"Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity","volume":"36","author":"John","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2020.04.018_bib53","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/infdis\/jix592","article-title":"Modified mRNA-based vaccines elicit robust immune responses and protect guinea pigs from Ebola virus disease","volume":"217","author":"Meyer","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ymthe.2020.04.018_bib54","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1038\/s41467-018-05482-0","article-title":"Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies","volume":"9","author":"Pardi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2020.04.018_bib55","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3389\/fimmu.2017.01539","article-title":"Induction of robust B cell responses after influenza mRNA vaccination is accompanied by circulating hemagglutinin-specific ICOS+ PD-1+ CXCR3+ T follicular helper cells","volume":"8","author":"Lindgren","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-017-0032-6","article-title":"Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines","volume":"2","author":"Lutz","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ymthe.2020.04.018_bib57","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.vaccine.2019.04.074","article-title":"mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials","volume":"37","author":"Feldman","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2020.04.018_bib58","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1128\/JVI.02608-13","article-title":"Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain","volume":"88","author":"Eggink","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib59","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/JVI.01786-15","article-title":"Induction of Broad-Based Immunity And Protective Efficacy By Self-Amplifying mRNA vaccines encoding influenza virus hemagglutinin","volume":"90","author":"Brazzoli","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.04.018_bib60","doi-asserted-by":"crossref","first-page":"e0161193","DOI":"10.1371\/journal.pone.0161193","article-title":"Self-amplifying mRNA vaccines expressing multiple conserved influenza antigens confer protection against homologous and heterosubtypic viral challenge","volume":"11","author":"Magini","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2020.04.018_bib61","doi-asserted-by":"crossref","first-page":"E4133","DOI":"10.1073\/pnas.1600299113","article-title":"Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose","volume":"113","author":"Chahal","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.04.018_bib62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"81","key":"10.1016\/j.ymthe.2020.04.018_bib63","first-page":"e51112","article-title":"Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system","author":"Margine","year":"2013","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2020.04.018_bib64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from in\u00a0vitro-transcribed mRNA","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620301994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620301994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:04:58Z","timestamp":1778616298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620301994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1525001620301994"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.04.018","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.06.017","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}